Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04116437
Brief Title: Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment

First Submitted : October 1, 2019
First Submitted that Met QC Criteria : October 2, 2019
First Posted : October 4, 2019

Last Update Submitted that Met QC Criteria : December 4, 2020
Last Update Posted : December 7, 2020